Bruker reports Q3 2026 revenue up 1.6% and non‑GAAP EPS of $0.56, reaffirming FY 2026 guidance

Bruker Corporation posted third‑quarter 2026 revenue of $874.0 million, a 1.6% increase year‑over‑year on a reported basis and 0.7% organic growth. Non‑GAAP diluted earnings per share were $0.56, up 24.4% from the prior year, while GAAP results showed a loss per share of $(0.81) after a $174.5 million goodwill impairment. The company reaffirmed its FY 2026 outlook of 1%‑2% organic revenue growth and non‑GAAP EPS of $2.10‑$2.15, and highlighted continued margin expansion and strong bookings in its Bruker Scientific Instruments segment.

The reaffirmed FY 2026 guidance signals that investors can expect modest top‑line growth and 15%‑17% non‑GAAP EPS growth year‑over‑year, according to the company’s filing. The 400‑basis‑point rise in non‑GAAP operating margin to 16.3% improves profitability outlook.

  • 1Q3 2026 reported revenue was $874.0 million, up 1.6% year‑over‑year (reported basis).
  • 2Q3 2026 organic revenue growth was 0.7% year‑over‑year.
  • 3Non‑GAAP diluted EPS for Q3 2026 was $0.56, up 24.4% from Q3 2025 (non‑GAAP basis).
  • 4GAAP diluted loss per share for Q3 2026 was $(0.81).
  • 5Non‑GAAP operating margin for Q3 2026 was 16.3%, an increase of 400 basis points year‑over‑year (non‑GAAP basis).
  • 6FY 2026 guidance: organic revenue growth of 1%‑2% and non‑GAAP EPS of $2.10‑$2.15.

Sources